Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
BSPG Laboratories is a specialized pharmaceutical manufacturer based in the United Kingdom, focusing on the production of high-purity alkaloids and their derivatives. The company is a leading global supplier of Scopolamine (Hyoscine), Hyoscine-N-butylbromide, and Hyoscine Hydrobromide, which are essential active pharmaceutical ingredients (APIs) used in treatments for motion sickness and gastrointestinal spasms. Operating from a state-of-the-art GMP-compliant facility at Discovery Park in Sandwich, BSPG provides both contract manufacturing services and bulk API supply to the global healthcare industry. In 2014, the company was acquired by Alchem International, a major phytochemical and API producer, enhancing its global distribution and manufacturing reach.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on BSPG Laboratories.